Ident. | Authors (with country if any) | Title |
---|
000461 |
Marc Humbert [France] ; Edmund M. T. Lau [France, Australie] ; David Montani [France] ; Xavier Jaïs [France] ; Oliver Sitbon [France] ; Gérald Simonneau [France] | Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension |
000582 |
Zanfina Ademi [Australie] ; Molla M. Huq [Australie] ; Danny Liew [Australie] ; Ph. Gabriel Steg [France] ; Deepak L. Bhatt [États-Unis] ; Mark Nelson [Australie] ; Christopher M. Reid [Australie] | The Impact of Lost Therapeutic Benefit (LTB) in High-Risk Hypertensive Patients: 2-Year Follow-Up Data from the Australian REACH Registry |
000662 |
Silvia Rain [Pays-Bas] ; M. Louis Handoko [Pays-Bas] ; Pia Trip [Pays-Bas] ; C. Tji-Joong Gan [Pays-Bas] ; Nico Westerhof [Pays-Bas] ; Ger J. Stienen [Pays-Bas] ; Walter J. Paulus [Pays-Bas] ; Coen A. C. Ottenheijm [Pays-Bas] ; J. Tim Marcus [Pays-Bas] ; Peter Dorfmüller [France] ; Christophe Guignabert [France] ; Marc Humbert [France] ; Peter Macdonald [Australie] ; Cris Dos Remedios [Australie] ; Piet E. Postmus [Pays-Bas] ; Chandra Saripalli [États-Unis] ; Carlos G. Hidalgo [États-Unis] ; Henk L. Granzier [États-Unis] ; Anton Vonk-Noordegraaf [Pays-Bas] ; Jolanda Van Der Velden [Pays-Bas] ; Frances S. De Man [Pays-Bas] | Right Ventricular Diastolic Impairment in Patients With Pulmonary Arterial Hypertension |
000901 |
Carla Canniffe [Irlande (pays)] ; Phalla Ou [France] ; Kevin Walsh [Irlande (pays)] ; Damien Bonnet [France] ; David Celermajer [Australie] | Hypertension after repair of aortic coarctation - A systematic review |
000B86 |
C. Delcourt [Australie] ; C. Stapf [France] ; C. Tzourio [France] ; S. Heritier [Australie] ; C. Anderson [Australie] | La seconde phase d'une étude randomisée, multicentrique évaluant en ouvert l'effet de la réduction intensive de la pression artérielle dans l'hémorragie cérébrale (INTERACT2): protocole et caractéristiques des patients inclus en France |
000C09 |
Patrick Rossignol [France] ; Joelle Cridlig [France] ; Philippe Lehert [Belgique, Australie] ; Michele Kessler [France] ; Faiez Zannad [France] | Visit-to-Visit Blood Pressure Variability Is a Strong Predictor of Cardiovascular Events in Hemodialysis Insights From FOSIDIAL |
000C26 |
Isabelle Wolowczuk [France] ; Benjamin Hennart [France] ; Audrey Leloire [France] ; Alban Bessede [Australie] ; Marion Soichot [France] ; Solenne Taront [France] ; Robert Caiazzo [France] ; Violeta Raverdy [France] ; Marie Pigeyre [France] ; Abos Consortium [France] ; Gilles J. Guillemin [Australie] ; Delphine Allorge [France] ; François Pattou [France] ; Philippe Froguel [France, Royaume-Uni] ; Odile Poulain-Godefroy [France] | Tryptophan metabolism activation by indoleamine 2,3-dioxygenase in adipose tissue of obese women: an attempt to maintain immune homeostasis and vascular tone |
000E45 |
Xavier Jaïs [France] ; Karen M. Olsson [Allemagne] ; Joan A. Barbera [Espagne] ; Isabel Blanco [Espagne] ; Adam Torbicki [Pologne] ; Andrew Peacock [Royaume-Uni] ; C. Dario Vizza [Italie] ; Peter Macdonald [Australie] ; Marc Humbert [France] ; Marius M. Hoeper [Allemagne] | Pregnancy outcomes in pulmonary arterial hypertension in the modern management era |
000F12 |
Stéphane Laurent [France] ; Markus Schlaich [Australie] ; Murray Esler [Australie] | New drugs, procedures, and devices for hypertension |
001179 |
Hisatomi Arima [Australie] ; Craig Anderson [Australie] ; Teruo Omae [Japon] ; Mark Woodward [Australie] ; Stephen Macmahon [Australie, Royaume-Uni] ; Giuseppe Mancia [Italie] ; Marie-Germaine Bousser [France] ; Christophe Tzourio [France] ; Anthony Rodgers [Australie] ; Bruce Neal [Australie] ; John Chalmers [Australie] | Effects of Blood Pressure Lowering on Intracranial and Extracranial Bleeding in Patients on Antithrombotic Therapy: The PROGRESS Trial |
001299 |
Amanda J. Rickard [Australie, France] ; James Morgan [Australie] ; Laura A. Bienvenu [Australie] ; Elizabeth K. Fletcher [Australie] ; Greg A. Cranston [Australie] ; Jimmy Z. Shen [Australie] ; Melissa E. Reichelt [Australie] ; Lea M. Delbridge [Australie] ; Morag J. Young [Australie] | Cardiomyocyte Mineralocorticoid Receptors Are Essential for Deoxycorticosterone/Salt-Mediated Inflammation and Cardiac Fibrosis |
001340 |
Bakhtawar K. Mahmoodi [États-Unis, Pays-Bas] ; Kunihiro Matsushita [États-Unis] ; Mark Woodward [États-Unis, Australie] ; Pester Blankestijn [Pays-Bas] ; Massimo Cirillo [Italie] ; Takayoshi Ohkubo [Japon] ; Peter Rossing [Danemark] ; Mark J. Sarnak [États-Unis] ; Benedicte Stengel [France] ; Kazumasa Yamagishi [Japon] ; Kentaro Yamashita [Japon] ; LUXIA ZHANG [République populaire de Chine] ; Josef Coresh [États-Unis] ; Paul E. De Jong [Pays-Bas] ; Brad C. Astor [États-Unis] | Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis |
001577 |
Sébastien Czernichow [Australie, France] ; Alberto Zanchetti [Italie] ; Fiona Turnbull [Australie] ; Federica Barzi [Australie] ; Toshiaru Ninomiya [Australie] ; André-Pascal Kengne [Australie] ; Hiddo J. Lambers Heerspink [Pays-Bas] ; Vlado Perkovic [Australie] ; Rachel Huxley [Australie] ; Hisatomi Arima [Australie] ; Anushka Patel [Australie] ; John Chalmers [Australie] ; Mark Woodward [Australie] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] | The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials |
001686 |
Jacqueline L. Webster [Australie] ; Elizabeth K. Dunford [Australie] ; Corinna Hawkes [France, Royaume-Uni] ; Bruce C. Neal [Australie] | Salt reduction initiatives around the world |
001710 |
Kesia Palma-Rigo [Australie, France] ; Kristy L. Jackson [Australie] ; Pamela J. Davern [Australie] ; Thu-Phuc Nguyen-Huu [Australie] ; Jean-Luc Elghozi [France] ; Geoffrey A. Head [Australie] | Renin-angiotensin and sympathetic nervous system contribution to high blood pressure in Schlager mice |
001763 |
RUI YANG [Belgique] ; Ilse Smolders [Belgique] ; Patrick Vanderheyden [Belgique] ; Heidi Demaegdt [Belgique] ; Ann Van Eeckhaut [Belgique] ; Georges Vauquelin [Belgique] ; Aneta Lukaszuk [Belgique] ; Dirk Tourwe [Belgique] ; Siew Yeen Chai [Australie] ; Anthony L. Albiston [Australie] ; Clara Nahmias [France] ; Thomas Walther [Royaume-Uni] ; Alain G. Dupont [Belgique, Allemagne] | Pressor and Renal Hemodynamic Effects of the Novel Angiotensin A Peptide Are Angiotensin II Type 1A Receptor Dependent |
001A71 |
Pascal Rossi [France] ; Yves Frances [France] ; Bronwyn A. Kingwell [Australie] ; Anna A. Ahimastos [Australie] | Gender differences in artery wall biomechanical properties throughout life |
001B53 |
David A. Calhoun [États-Unis] ; William B. White [États-Unis] ; Henry Krum [Australie] ; WEINONG GUO [États-Unis] ; Georgina Bermann [Suisse] ; Angelo Trapani [États-Unis] ; Martin P. Lefkowitz [États-Unis] ; Joel Menard [France] | Effects of a Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension: Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Phase 2 Trial |
001E05 |
Jasper J. Brugts [Pays-Bas] ; Aaron Isaacs [Pays-Bas] ; Moniek P. M. De Maat [Pays-Bas] ; Eric Boersma [Pays-Bas] ; Cock M. Van Duijn [Pays-Bas] ; K. Martijn Akkerhuis [Pays-Bas] ; Andre G. Uitterlinden [Pays-Bas] ; Jacqueline C. M. Witteman [Pays-Bas] ; Francois Cambien [France] ; Claudio Ceconi [Italie] ; Willem Remme [Pays-Bas] ; Michel Bertrand [France] ; Toshiharu Ninomiya [Australie] ; Stephen Harrap [Australie] ; John Chalmers [Australie] ; Stephen Macmahon [Australie] ; Kim Fox [Royaume-Uni] ; Roberto Ferrari [Italie] ; Maarten L. Simoons [Pays-Bas] ; A. H. Jan Danser [Pays-Bas] | A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals |
001F73 |
L. Fezeu [France, Cameroun] ; A. P. Kengne [Cameroun, Australie] ; B. Balkau [France] ; P. K. Awah [Cameroun] ; J. C. Mbanya [Cameroun] | Ten-year change in blood pressure levels and prevalence of hypertension in urban and rural Cameroon |
002130 |
Charatambos Vlachopoulos [Grèce] ; Konstantinos Aznaouridis [Grèce] ; Michael F. O'Rourke [Australie] ; Michel E. Safar [France] ; Katerina Baou [Grèce] ; Christodoulos Stefanadis [Grèce] | Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis |
002158 |
Hisatomi Arima [Australie] ; Craig Anderson [Australie] ; Teruo Omae [Japon] ; LISHENG LIU [République populaire de Chine] ; Christophe Tzourio [France] ; Mark Woodward [États-Unis] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] ; Anthony Rodgers [Australie] ; John Chalmers [Australie] | Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial |
002262 |
Sébastien Czernichow [France] ; Jerry R. Greenfield [Australie] ; Pilar Galan [France] ; Jean-Philippe Bastard [France] ; Nathalie Charnaux [France] ; Katherine Samaras [Australie] ; Michel E. Safar [France] ; Jacques Blacher [France] ; Serge Hercberg [France] ; Bernard I. Levy [France] | Microvascular dysfunction in healthy insulin-sensitive overweight individuals |
002329 |
Duncan J. Campbell [Australie] ; Habib Karam [France] ; Patrick Bruneval [France] ; John J. Mullins [Royaume-Uni] ; Joël Menard [France] | Increased dietary NaCl potentiates the effects of elevated prorenin levels on blood pressure and organ disease |
002339 |
Sébastien Czernichow [Australie, France] ; Toshiharu Ninomiya [Australie] ; Rachel Huxley [Australie] ; André-Pascal Kengne [Australie] ; G. David Batty [Australie, Royaume-Uni] ; Diederick E. Grobbee [Pays-Bas] ; Mark Woodward [Australie] ; Bruce Neal [Australie] ; John Chalmers [Australie] | Impact of Blood Pressure Lowering on Cardiovascular Outcomes in Normal Weight, Overweight, and Obese Individuals: The Perindopril Protection Against Recurrent Stroke Study Trial |
002467 |
Liffert Vogt [Pays-Bas, Italie] ; Carlos Chiurchiu [Italie] ; Harbajan Chadha-Boreham [Suisse] ; Parisa Danaietash [Suisse] ; Jasper Dingemanse [Suisse] ; Samy Hadjadj [France] ; Henry Krum [Australie] ; Gerjan Navis [Pays-Bas] ; Eric Neuhart [Suisse] ; Aneliya I. Parvanova [Italie] ; Piero Ruggenenti [Italie] ; Arend Jan Woittiez [Pays-Bas] ; Reuven Zimlichman [Israël] ; Giuseppe Remuzzi [Italie] ; Dick De Zeeuw [Pays-Bas] | Effect of the Urotensin Receptor Antagonist Palosuran in Hypertensive Patients With Type 2 Diabetic Nephropathy |
002476 |
Otylia Kowal-Bielecka [Pologne, France, Allemagne, Royaume-Uni, Italie, Australie, États-Unis, Suisse] ; Jerome Avouac ; David Pittrow ; Doerte Huscher ; Frank Behrens ; Christopher P. Denton ; Ivan Foeldvari ; Marc Humbert ; Marco Matucci-Cerinic ; Peter Nash ; Christian F. Opitz ; Lewis J. Rubin ; James R. Seibold ; Vibeke Strand ; Daniel E. Furst ; Oliver Distler | Echocardiography as an Outcome Measure in Scleroderma-related Pulmonary Arterial Hypertension: A Systematic Literature Analysis by the EPOSS Group |
002856 |
Carole Dufouil [France] ; Ophélia Godin [France] ; John Chalmers [Australie] ; Oghuzan Coskun [France] ; Stephen Macmahon [Australie] ; Nathalie Tzourio-Mazoyer [France] ; Marie-Germaine Bousser [France] ; Craig Anderson [Australie] ; Bernard Mazoyer [France] ; Christophe Tzourio [France] | Severe Cerebral White Matter Hyperintensities Predict Severe Cognitive Decline in Patients With Cerebrovascular Disease History |
002866 |
Alberto P. Avolio [Australie] ; Luc M. Van Bortel [Belgique] ; Pierre Boutouyrie [Belgique] ; John R. Cockcroft [France] ; Carmel M. Mceniery [France] ; Athanase D. Protogerou [Royaume-Uni] ; Mary J. Roman [Royaume-Uni] ; Michel E. Safar [Grèce] ; Patrick Segers [États-Unis] ; Harold Smulyan [États-Unis] | Role of Pulse Pressure Amplification in Arterial Hypertension: Experts' Opinion and Review of the Data |
002911 |
Duncan J. Campbell [Australie] ; Habib Karam [France] ; Joël Menard [France] ; Patrick Bruneval [France] ; John J. Mullins [Royaume-Uni] | Prorenin Contributes to Angiotensin Peptide Formation in Transgenic Rats With Rat Prorenin Expression Targeted to the Liver |
002C56 |
Ruth Peters [Royaume-Uni] ; Ruth Poulter [Royaume-Uni] ; Nigel Beckett [Royaume-Uni] ; Françoise Forette [France] ; Robert Fagard [Belgique] ; John Potter [Royaume-Uni] ; Cameron Swift [Royaume-Uni] ; Craig Anderson [Australie] ; Astrid Fletcher [Royaume-Uni] ; Christopher J. Bulpitt [Royaume-Uni] | Cardiovascular and biochemical risk factors for incident dementia in the Hypertension in the Very Elderly Trial |
002C57 |
Claude Julien [France] ; Sandra L. Burke [Australie] ; Geoffrey A. Head [Australie] | Cardiac and renal baroreflex control during stress in conscious renovascular hypertensive rabbits : effect of rilmenidine. Commentary |
002C66 |
Andre-Pascal Kengne [Australie] ; Sébastien Czernichow [France] ; Rachel Huxley [Australie] ; Diederick Grobbee [Pays-Bas] ; Mark Woodward [États-Unis] ; Bruce Neal [Australie] ; Sophia Zoungas [Australie] ; Mark Cooper [Australie] ; Paul Glasziou [Royaume-Uni] ; Pavel Hamet [Canada] ; Stephen B. Harrap [Australie] ; Giuseppe Mancia [Italie] ; Neil Poulter [Royaume-Uni] ; Bryan Williams [Royaume-Uni] ; John Chalmers [Australie] | Blood Pressure Variables and Cardiovascular Risk: New Findings From ADVANCE |
002E10 |
Nigel S. Beckett [Royaume-Uni] ; Ruth Peters [Royaume-Uni] ; Astrid E. Fletcher [Royaume-Uni] ; Jan A. Staessen [Belgique] ; LISHENG LIU [République populaire de Chine] ; Dan Dumitrascu [Roumanie] ; Vassil Stoyanovsky [Bulgarie] ; Riitta L. Antikainen [Royaume-Uni, Finlande] ; Yuri Nikitin [Russie] ; Craig Anderson [Australie] ; Alli Belhani [Tunisie] ; Francoise Forette [France] ; Chakravarthi Rajkumar [Royaume-Uni] ; Lutgarde Thijs [Belgique] ; Winston Banya [Royaume-Uni] ; Christopher J. Bulpitt [Royaume-Uni] | Treatment of Hypertension in Patients 80 Years of Age or Older |
003168 |
Sébastien Czernichow [France] ; Jerry R. Greenfield [Australie] ; Michel E. Safar [France] ; Olebogeng H. I. Majane [Afrique du Sud] ; Angela J. Woodiwiss [Afrique du Sud] ; Muzi J. Maseko [Afrique du Sud] ; Nigel J. Crowther [Afrique du Sud] ; Patrick H. Dessein [Afrique du Sud] ; Gavin R. Norton [Afrique du Sud] | Impact of Age on the Independent Association of Adiposity With Pulse-wave Velocity in a Population Sample of African Ancestry. Commentary |
003214 |
Michel Azizi [France] ; Costanza Emanueli [Royaume-Uni] ; Severine Peyrard [France] ; Paolo Maddedu [Royaume-Uni] ; Francois Alhenc-Gelas [France] ; Duncan J. Campbell [Australie] | Genetic and dietary control of plasma tissue kallikrein secretion and urinary kinins exretion in man |
003368 |
Emil Toader [France] ; Andrei Cividjian [France] ; Nicolas Rentero [France] ; Robin M. Mcallen [Australie] ; Luc Quintin [France] | Cardioinhibitory actions of clonidine assessed by cardiac vagal motoneuron recordings |
003410 |
Sebastien Fuchs [États-Unis] ; Hong D. Xiao [États-Unis] ; Christine Hubert [France] ; Annie Michaud [France] ; Duncan J. Campbell [Australie] ; Jonathan W. Adams [États-Unis] ; Mario R. Capecchi [Australie] ; Pierre Corvol [France] ; Kenneth E. Bernstein [États-Unis] | Angiotensin-Converting Enzyme C-Terminal Catalytic Domain Is the Main Site of Angiotensin I Cleavage In Vivo |
003550 |
Giuseppe Mancia [Italie] ; Pascal Bousquet [France] ; Jean Luc Elghozi [France] ; Murray Esler [Australie] ; Guido Grassi [Italie] ; Stevo Julius [États-Unis] ; John Reid [Royaume-Uni] ; Peter A. Van Zwieten [Pays-Bas] | The sympathetic nervous system and the metabolic syndrome |
003734 |
Henry Krum [Australie] ; Richard E. Gilbert [Canada, Australie] ; Joël Menard [France] | Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders. Commentary |
003991 |
E. Marijon [Mozambique, France] ; L. Trinquart [France] ; D. Jani [Mozambique] ; H. Jourdier [Mozambique] ; E. Garbarz [France] ; A. O. Mocumbi [Mozambique] ; D. S. Celermajer [Australie] ; B. Ferreira [Mozambique] | Coronary heart disease and associated risk factors in sub-Saharan Africans |
003A21 |
Paul Elliott [Royaume-Uni] ; Lesley L. Walker [Australie] ; Mark P. Little [Royaume-Uni] ; John R. Blair-West [Australie, États-Unis] ; Robert E. Shade [États-Unis] ; D. Rick Lee [États-Unis] ; Pierre Rouquet [Gabon] ; Eric Leroy [Gabon] ; Xavier Jeunemaitre [France] ; Raymond Ardaillou [France] ; Francoise Paillard [France] ; Pierre Meneton [France] ; Derek A. Denton [États-Unis, Australie] | Change in salt intake affects blood pressure of chimpanzees : Implications for human populations |
003A25 |
Philippe Gosse [France] ; Georgios Papaioanou [France] ; Paul Coulon [France] ; Sylvain Reuter [France] ; Philippe Lemetayer [France] ; Michel Safar [France] ; Michael F. O'Rourke [Australie] | Can ambulatory blood-pressure monitoring provide reliable indices of arterial stiffness? |
003D31 |
John Chalmers [Australie] ; Nikola Sprigg [Royaume-Uni] ; Laura J. Gray [Royaume-Uni] ; Philip M. W. Bath [Royaume-Uni] ; Gudrun Boysen [Danemark] ; Peter Paul De Deyn [Belgique] ; Pal Friis [Norvège] ; Didier Leys [France] ; Reijo Marttila [Finlande] ; Jan-Edwin Olsson [Suède] ; Desmond O'Neill [Irlande (pays)] ; Bernd Ringelstein [Allemagne] ; Jan-Jacob Van Der Sande [Pays-Bas] ; Ewa Lindenstr M [Danemark] | Relationship between outcome and baseline blood pressure and other haemodynamic measures in acute ischaemic stroke : data from the TAIST trial. Commentary |
003D32 |
Olivier Hanon [France] ; Renaud Pequignot [France] ; Marie Laure Seux [France] ; Hermine Lenoir [France] ; Alexandra Bune [Australie] ; Anne Sophie Rigaud [France] ; Francoise Forette [France] ; Xavier Girerd [France] | Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints |
003D83 |
Jérome Rossert [France, Canada, Australie, Autriche, États-Unis, Suisse] ; Adeera Levin ; Simon D. Roger ; Walter H. Hörl ; Bruno Fouqueray ; Cristiana Gassmann-Mayer ; Dieter Frei ; William M. Mcclellan | Pathogenesis and treatment of kidney disease and hypertension : Effect of early correction of anemia on the progression of CKD |
003F04 |
Hisatomi Arima [Australie] ; John Chalmers [Australie] ; Mark Woodward [Australie] ; Craig Anderson [Australie] ; Anthony Rodgers [Nouvelle-Zélande] ; Stephen Davis [Australie] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] | Lower target blood pressures are safe and effective for the prevention of recurrent stroke : the PROGRESS trial |
004183 |
Carlene M. M. Lawes [Nouvelle-Zélande] ; Stephen Vander Hoorn [Nouvelle-Zélande] ; Malcolm R. Law [Royaume-Uni] ; Paul Elliott [Royaume-Uni] ; Stephen Macmahon [Australie] ; Anthony Rodgers [Nouvelle-Zélande] ; Francois Gueyffier [France] ; James Wright [Canada] | Blood pressure and the global burden of disease 2000. Part II: Estimates of attributable burden. Commentary |
004405 |
Bruce Neal [Australie] ; Athanase Benetos [France] ; Frédérique Thomas [France] ; Kathryn E. Bean [France] ; Bruno Pannier [France] ; Louis Guize [France] | Role of modifiable risk factors in life expectancy in the elderly. Commentary |
004414 |
Michael F. O'Rourke [Australie] ; Michel E. Safar [France] | Relationship between aortic stiffening and microvascular disease in brain and kidney : Cause and logic of therapy |
004438 |
G. A. Dekker [Australie, France] ; P. Y. Robillard | Preeclampsia: A couple's disease with maternal and fetal manifestations : Complications in pregnancy. Recent developments in preventive strategies and treatment modalities |
004439 |
Rodolphe Thiebaut [France] ; Wafaa M. El-Sadr [États-Unis] ; Nina Friis-M Ller [Danemark] ; Martin Rickenbach [Suisse] ; Peter Reiss [Pays-Bas] ; Antonella D'Arminio Monforte [Italie] ; Linda Morfeldt [Suède] ; Eric Fontas [France] ; Ole Kirk [Danemark] ; Stephane De Wit [Belgique] ; Gonzalo Calvo [Espagne] ; Matthew G. Law [Australie] ; Francois Dabis [France] ; Caroline A. Sabin [Royaume-Uni] ; Jens D. Lundgren [Danemark] | Predictors of hypertension and changes of blood pressure in HIV-infected patients |
004572 |
DONG YOU [France] ; Laurent Loufrani [France] ; Celine Baron [France] ; Bernard I. Levy [France] ; Robert E. Widdop [Australie] ; Daniel Henrion [France] | High blood pressure reduction reverses angiotensin II type 2 receptor-mediated vasoconstriction into vasodilation in spontaneously hypertensive rats |
004640 |
Carole Dufouil [France] ; John Chalmers [Australie] ; Oguzhan Coskun [France] ; Véronique Besancon [France] ; Marie-Germaine Bousser [France] ; Pierre Guillon [France] ; Stephen Macmahon [Australie] ; Bernard Mazoyer [France] ; Bruce Neal [Australie] ; Mark Woodward [Australie] ; Nathalie Tzourio-Mazoyer [France] ; Christophe Tzourio [France, Australie] | Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke : The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) magnetic resonance imaging substudy |
004731 |
Athanase Benetos [France] ; Oscar H. Franco [Pays-Bas] ; Anna Peeters [Australie] ; Luc Bonneux [Belgique] ; Chris De Laet [Pays-Bas, Belgique] | Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women : Life course analysis. Commentary |
004743 |
Alex Bobik [Australie] ; Philippe Hudlett [France] ; Agnès Neuville [France] ; Anne Miternique [France] ; Christophe Griffon [France] ; Denis Weltin [France] ; Dominique Stephan [France] | Angiogenesis and arteriogenesis are increased in fibrin gel chambers implanted in prehypertensive spontaneously hypertensive rats |
004867 |
Jean-Michel Mallion [France] ; Bernard Chamontin [France] ; Roland Asmar [France] ; Peter Wilhelmus De Leeuw [Pays-Bas] ; Eoin O'Brien [Irlande (pays)] ; Daniel Duprez [Belgique, États-Unis] ; Michael F. O'Rourke [Australie] ; Karl-Heinz Rahn [Allemagne] ; Ramon Romero [Espagne] ; Edouard Battegay [Suisse] ; Gerhart Hitzenberger [Autriche] ; Michel E. Safar [France] | Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: The REASON study |
004947 |
Nicola De Luca [Italie] ; Roland G. Asmar [France] ; Gérard M. London [France] ; Michael F. O'Rourke [Australie] ; Michel E. Safare [France] | Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects |
004964 |
Jacques Amar [France] ; Jean-Bernard Ruidavets [France] ; Claire Bal Dit Sollier [France] ; Vanina Bongard [France] ; Henri Boccalon [France] ; Bernard Chamontin [France] ; Ludovic Drouet [France] ; Jean Ferrieres [France] ; Alberto Avolio [Australie] | Relationship between C reactive protein and pulse pressure is not mediated by atherosclerosis or aortic stiffness. Commentary |
004966 |
Nicola De Luca [Italie] ; Jean-Michel Mallion [France] ; Michael F. O'Rourke [Australie] ; Eoin O'Brien [Irlande (pays)] ; Karl-Heinz Rahn [Allemagne] ; Bruno Trimarco [Italie] ; Ramon Romero [Espagne] ; Peter Wilhelmus De Leeuw [Pays-Bas] ; Gerhart Hitzenberger [Autriche] ; Edouard Battegay [Suisse] ; Daniel Duprez [Belgique] ; Peter Sever [Royaume-Uni] ; Michel E. Safar [France] | Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: The REASON echocardiography study |
004A11 |
Anthony Rodgers [Nouvelle-Zélande] ; Neil Chapman [Australie] ; Mark Woodward [Australie] ; Li-Sheng Liu [République populaire de Chine] ; Sam Colman [Australie] ; Arier Lee [Nouvelle-Zélande] ; John Chalmers [Australie] ; Stephen Macmahon [Australie] ; Francois Gueyffier [France] | Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region. Commentary |
004A68 |
Gérard M. London [France] ; Roland G. Asmar [France] ; Michaël F. O'Rourke [Australie] ; Michel E. Safar [France] | Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: Comparison with atenolol |
004D28 |
John Chalmers [Australie] | Etude ADVANCE: objectifs, protocole et état actuel |
004F33 |
Pierre Albaladejo [France] ; Pierre Laurent [États-Unis] ; Bruno Pannier [France] ; Apostolos Achimastos [Grèce] ; Michel Safar [France] ; Athanase Benetos [France] ; Michael F. O'Rourke [Australie] ; Chris S. Hayward [Australie] | Influence of sex on the relation between heart rate and aortic stiffness. Editorial Commentaries |
005478 |
John B. Kostis [États-Unis] ; Stuart Cobbe [Royaume-Uni] ; Colin Johnston [Australie] ; Ian Ford [Royaume-Uni] ; Michael Murphy [Irlande (pays)] ; Michael A. Weber [États-Unis] ; Henry R. Black [France] ; Pierre Francois Plouin [France] ; Daniel Levy [États-Unis] ; Guiseppe Mancia [Italie] ; Pierre Larochelle [Canada] ; Rainer E. Kolloch [Allemagne] ; Michael Alderman [États-Unis] ; Luis Miguel Ruilope [Espagne] ; Björn Dahlöf [Suède] ; John M. Flack [États-Unis] ; Robert Wolf [États-Unis] | Design of the Omapatrilat in Persons with Enhanced Risk of atherosclerotic events (OPERA) trial |
005508 |
Stéphane Laurent [France] ; Bronwyn Kingwell [Australie] ; Alan Bank [États-Unis] ; Michael Weber [États-Unis] ; Harry Struijker-Boudier [Pays-Bas] | Clinical applications of arterial stiffness: Therapeutics and pharmacology |
005703 |
Robert W. G. Johnson [Royaume-Uni] ; Henri Kreis [France] ; Rainer Oberbauer [Autriche] ; Christina Brattström [Suède] ; Kerstin Claesson [Suède] ; Josette Eris [Australie] | Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure |
005833 |
Roland G. Asmar [France] ; Gérard M. London [France] ; Michael E. O'Rourke [Australie] ; Michel E. Safar [France] | Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: A comparison with atenolol |
005C26 |
J. Chalmers [Australie] ; A. Castaigne [France] ; T. Morgan [Australie] ; C. Chastang [France] | Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients |
005C60 |
Cécile Dufour [France] ; Didier Casane [France] ; Derek Denton [Australie] ; Jean Wickings [Gabon] ; Pierre Corvol [France] ; Xavier Jeunemaitre [France] | Human-chimpanzee DNA sequence variation in the four major genes of the renin angiotensin system |
006065 |
A. Castaigne [France] ; J. Chalmers [Australie] ; T. Morgan [Australie] ; C. Chastang [France] ; L. Feldmann [France] ; D. Guez [France] | Efficacy and safety of an oral fixed low-dose perindopril 2 mg/indapamide 0.625 mg combination : A randomized, double-blind, placebo-controlled study in elderly patients with mild to moderate hypertension |
006216 |
T. Morgan [Australie] ; J. Menard [France] ; H. Brunner [Suisse] | Twenty-four hour blood pressure control and trough to peak ratio : who, when, how and why? : Trough to peak ratios |
006218 |
T. Morgan [Australie] ; J. Menard [France] ; H. Brunner [Suisse] | Trough to peak ratio as a guide to BP control: measurement and calculation : Trough to peak ratios |
006253 |
E. Brand [France] ; N. Kato [Royaume-Uni] ; N. Chatelain [France] ; Z. S. Krozowski [Australie] ; X. Jeunemaitre [France] ; P. Corvol [France] ; P.-F. Plouin [France] ; F. Cambien [France] ; L. Pascoe [France] ; F. Soubrier [France] | Structural analysis and evaluation of the 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) gene in human essential hypertension |
006287 |
P. Mulatero [France, Italie] ; K. M. Curnow [France, Australie] ; B. Aupetit-Faisant [France] ; M. Foekling [États-Unis] ; C. Gomez-Sanchez [États-Unis] ; F. Veglio [Italie] ; X. Jeunemaitre [France] ; P. Corvol [France] ; L. Pascoe [France] | Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol |
006384 |
R. M. Schaefer [Allemagne] ; P. M. Aldons ; E. D. Burgess ; R. Tilvis [Finlande] ; X. Girerd [France] ; G. P. Singh [Nouvelle-Zélande] ; L. Rehn ; T. O. Morgan [Australie] | Improved tolerability of felodipine compared with amlodipine in elderly hypertensives : A randomised, double-blind study in 535 patients, focusing on vasodilatory adverse events |
006429 |
K. M. Webber [Australie] ; C. A. Wallace [Australie] ; A. I. Smith [Australie] ; M. Van Den Buuse [Australie] | Endothelin interactions with brain dopamine systems |
006557 |
G. Morineau [France] ; L. Pascoe [France] ; J.-M. Marc [France] ; A. Caillette [France] ; Z. Krozowski [Australie] ; P. Corvol [France] ; J. Fiet [France] | Un cas d'excès apparent de minéralocorticoïdes par déficit en 11 β hydroxystéroïdedéshydrogénase de type 2 |
006609 |
J. Menard [France] ; D. J. Campbell [Australie] ; M. Azizi [France] ; M.-F. Gonzales [France] | Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats |
006834 |
| |
006A34 |
M. Esler [Australie] | Sympathetic nervous system : Contribution to human hypertension and related cardiovascular diseases |
006B04 |
R. W. Sanson-Fisher [Australie] ; K. Clover | Compliance in the treatment of hypertension : a need for action |
006B14 |
G. A. Head [Australie] | Baroreflexes and cardiovascular regulation in hypertension |
006B94 |
L. Hansson [Suède] | The place of β-blockers in the treatment of hypertension in 1993 |
006B95 |
C. I. Johnston [Australie] | The place of diuretics in the treatment of hypertension in 1993 : can we do better ? |
006B96 |
J. Chalmers [Australie] | The place of combination therapy in the treatment of hypertension in 1993 |
006B97 |
J. L. Reid [Royaume-Uni] | The place of alpha blockers in the treatment of hypertension |
006B99 |
S. Macmahon [Nouvelle-Zélande] ; A. Rodgers | The effects of blood pressure reduction in older patients : an overview of five randomized controlled trials in elderly hypertensives |
006C05 |
B. Dahlöf [Suède] ; L. Hansson [Suède] ; L. H. Lindholm ; B. Schersten ; T. Ekbom ; P.-O. Wester | Swedish trial in old patients with hypertension (stop-hypertension) analyses performed up to 1992 |
006C15 |
P. Sleight [Royaume-Uni] | Smoking and hypertension |
006C16 |
G. Bobrie [France] ; M. Day ; A. Tugaye ; G. Chatellier ; J. Menard | Self blood pressure measurement at home |
006C28 |
K. A. Jamerson [États-Unis] | Prevalence of complications and response to different treatments of hypertension in African Americans and white Americans in the U.S. |
006C38 |
P. A. Van Zwieten [Pays-Bas] | New avenues in antihypertensive drug treatment |
006C42 |
A. Mimran [France] ; J. Ribstein | Microalbuminuria in essential hypertension |
006C47 |
A. F. Lever [Royaume-Uni] ; P. J. Brennan | MRC trial of treatment in elderly hypertensives |
006C49 |
R. B. Devereux [États-Unis] ; G. De Simone ; A. Ganau ; M. J. Koren ; G. A. Mensah ; M. J. Roman | Left ventricular hypertrophy and hypertension |
006C58 |
P. Passa [France] | Insulin resistance and hypertension |
006C64 |
LIU LISHENG [République populaire de Chine] | Hypertension studies in China |
006C65 |
P. K. Whelton [États-Unis] ; F. Brancati | Hypertension management in populations |
006C66 |
L. H. Lindholm [Suède] ; T. Ekbom | Hypertension in the elderly |
006C67 |
A. Svensson [Suède] | Hypertension in pregnancy |
006C68 |
A. Beltrame Ribeiro [Brésil] | Hypertension in latin America : importance and approaches to control |
006C69 |
B. Falkner [États-Unis] | Hypertension in childhood and adolescence |
006C70 |
L. A. Salako [Nigeria] | Hypertension in Africa and effectiveness of its management with various classes of antihypertensive drugs and in different socio-economic and cultural environments |
006C71 |
M. F. O'Rourke [Australie] | Hypertension and the conduit and cushioning functions of the arterial tree |
006C72 |
K. Arakawa [Japon] | Hypertension and exercise |
006C73 |
P. Hamet [Canada] | Hypertension and diabetes |
006C90 |
C. J. Bulpitt [Royaume-Uni] ; A. E. Fletcher | Cost-effectiveness of the treatment of hypertension |
006C93 |
L. A. Moye [États-Unis] ; B. R. Davis [États-Unis] ; C. M. Hawkins [États-Unis] ; J. L. Probstfield | Conclusions and implications of the systolic hypertension in the elderly program |
006C94 |
A. F. Schaub [Suisse] ; A. Steiner ; W. Vetter | Compliance to treatment |
006C96 |
J. A. Cutler [États-Unis] | Combinations of lifestyle modification and drug treatment in management of mild-moderate hypertension : a review of randomized clinical trials |
006D01 |
F. C. Luft [Allemagne] ; H. Haller | Calcium channel blockers in current medical practice : an update for 1993 |
006D04 |
SAFAR ME [France] ; L. S [France] | Behaviour of conduit arteries in hypertension |
006D08 |
L. Thijs [Belgique] ; A. Amery ; R. Antikainen ; P. Bert ; W. Birkenh Ger ; C. J. Bulpitt ; C. T. Dollery ; A. E. Fletcher ; F. Forette ; T. Hakam Ki ; P. Kivinen ; E. Lehtomaki ; E. O'Brien ; C. Sarti ; J. Staessen ; R. Tilvis ; B. Trimarco ; J. Tuomilehto ; H. Vanhanen ; O. V Nska ; J. Webster ; Y. Yodfat | Antihypertensive therapy in elderly patients with isolated systolic hypertension : third progress report of the syst-eur trial |
006D10 |
J. L. Rodicio [Espagne] ; L. M. Ruilope | Angiotensin-converting enzyme inhibitors in the treatment of mild arterial hypertension |
006D11 |
H. R. Brunner [Suisse] ; J. Nussberger ; M. Burnier ; B. Waeber | Angiotensin II antagonists |
006D12 |
G. Mancia [Italie] ; A. Zanchetti | Ambulatory blood pressure monitoring in hypertension |
006D13 |
L. J. Beilin [Australie] ; I. B. Puddey | Alcohol, hypertension and cardiovascular disease : implications for management |
006D18 |
D. Levy [États-Unis] | A multifactorial approach to coronary disease risk assessment |
006D20 |
| |
006D23 |
| Functional and structural properties of large arteries |